期刊文献+

中国人小胰腺癌临床特征分析 被引量:12

An Analytic Study on Clinical Features of Small Pancreatic Adenocarcinoma in Chinese
在线阅读 下载PDF
导出
摘要 目的:探讨中国人小胰腺癌的临床特征。方法:以日本31例小胰腺癌及国内80例普通非小胰腺癌为对照组,分析研究经病理确诊的36例小胰腺癌的临床病理特征。结果:36例小胰腺癌34例(94.4%)有症状,33例(91.7%)位于胰头。首发及常见症状为黄疸,其中75.0%为无痛性黄疸。US、CT、ERCP诊断准确率分别为58.1%、65.2%、52.1%。19例(52.8%)处于Ⅰ期。总体1年生存率为63.9%,Ⅰ期者1年生存率为84.2%。结论:中国的小胰腺癌检测诊断较为滞后,应加强健康查体及卫生宣传,警惕不典型消化道症状。 Objective:To study the clinical features of small pancreatic cancer(PC)in Chi nese.Methods:The clinicopathological features of36pathologically diagnosed cases of small PC in Chinese were analysed in detail and it was compared with31cases of small PC in Japanese and80cases of non-small PC in Chinese as control.Results:Thirty-four (94.4%)of36cases had some clinical symptoms and signs.The initial clinical appearance of33patients with carcinoma of head of pancreas was jaundice,75.0%of them were painless,and laboratory test in a number of patients had elevated.The accuracy rates of ultrasonography,CT and ERCP were58.1%,65.2%,52.1%respectively.Nineteen patients were of stageⅠ.The overall1-year sur vival rate was63.6%and that of stageⅠpatients was86.0%.Conclusion:The detection and di agnosis of small PC in Chinese are somewhat late.Therefore,we should reinforce the health screening and hygienic propaganda and be cautious of atypical gastrointestinal symptoms.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第11期764-767,共4页 Chinese Journal of Clinical Oncology
基金 全军首批临床重大技术项目基金资助(编号:20)
关键词 中国人 胰腺肿瘤 病理学 诊断 分期 预后 Small pancreatic adenocarcinoma Pathology Diagnosis Stage classification Prognosis
  • 相关文献

参考文献13

  • 1[1]Ariyama J, Suyama M, Satoh K, et al. Imaging of small pan creatic ductal adenocarcinoma. Pancreas, 1998, 16(3): 396~401
  • 2[2]Fumkawa H, Okada S, Saisho H, et al. Clinicopathologic fea tures of small pancreatic adenocarcinoma A collective study.Cancer, 1996, 78(5): 986~990
  • 3[3]Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring Icm or less in diameter collective review of Japanese case reports. Hepatogastroenterology,1999, 46(25): 8~15
  • 4[4]Ritts RE, Pitt HA. CA19-9 in pancreatic cancer. Surg Oncol Clin N Am, 1998, 7(1): 93~101
  • 5[5]Nouts A, Levy P, Voitot H, et al. Diagnostic value of serumCA-19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterol Glin Biol, 1998, 22(2): 152~159
  • 6[6]Cappelli G, Paladini S, Agata A. Tumor markers in the diag nosis of pancreatic cancer. Tumori, 1999, 85(1 Suppl 1):19~21
  • 7[7]Mdaughlin R, O Hanlon D, Kerin M, et al. Are elevated levels of the tumor marker CA19-9 of any clinical signifi cance? -an evaluation. IrJ Med Sci, 1999, 168(2): 124~126
  • 8[8]Freeny PC, Lawson TL. Radiology of the pancreas. New York: Springer-Verlag, t982. 449
  • 9[9]Spinelli P, Schiavo M, Schicchi AA. Endoscopy in the diagno sis and staging of pancreatic cancer. Tumori, 1999, 85(1 Suppl 1): 14~18
  • 10[10]Okai T, Watanabe H, Yamaguchi Y, et al. EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass le sion: a prospective study. Gastrointest Endosc, 1999, 50(6): 797~803

同被引文献139

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部